Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Oncogene|September 29, 2015
Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulationC F de la Cruz-Herrera, M Baz-Martínez, V Lang, et al.
Diabetes Care|March 10, 2026
Accuracy, Variability, and Bias of Glycemic Biomarkers in Patients Treated With Maintenance DialysisLeila R Zelnick, Subbulaxmi Trikudanathan, Yoshio N Hall, et al.
Revista Argentina De Microbiologia|July 5, 2005
[First isolation of Histoplasma capsulatum from the urban bat Eumops bonariensis]C E Canteros, R H Iachini, M C Rivas, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 20, 2022
Predictors of Recurrence After Sub-total or Near-total Resection of Vestibular Schwannoma: Importance of Tumor Volume and Ventral ExtensionNauman F Manzoor, Ashley M Nassiri, Alexander D Sherry, et al.
Plos Neglected Tropical Diseases|August 18, 2025
Burden of Shigella among children with diarrhea in the Americas: A systematic review and meta-analysisMaya Lubeck-Schricker, Andrea C Rivas-Nieto, Jennifer Rosauer, et al.
Leukemia|January 6, 2007
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early interventionJ Esteve, L Escoda, G Martín, et al.
Haematologica|June 22, 2001
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIALJ J Ortega, J M Ribera, A Oriol, et al.
Blood|November 11, 1999
A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA groupM A Sanz, G Martín, C Rayón, et al.
Haematologica|August 28, 2001
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMAJ M Hernández, G Martín, N C Gutiérrez, et al.
British Journal of Haematology|July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA groupM González, E Barragán, P Bolufer, et al.
Pageof 28